Literature DB >> 18758925

Optimization of the near-infrared fluorescence labeling for in vivo monitoring of a protein drug distribution in animal model.

Huimin Qian1, Yueqing Gu, Min Wang, Samuel Achilefu.   

Abstract

The objective of this study is to optimize the parameters in labeling near-infrared (NIR)fluorescent dye cypate to protein drugs for in vivo optical imaging of drug distributions in animal model. L-ASparaginase (L-ASNase) was used as a protein drug model for the study. To achieve this goal, various labeling conditions, including different catalysts, feed ratios of all components, pH conditions, temperatures, and reacting durations, were investigated. The dye-to-protein (D/P) ratio and enzymatic activity were designated as the metric to evaluate the labeling process. The stability of the cypate-protein conjugate in blood serum and its distribution in small animals were subsequently inspected. Results showed that feed ratio of L-ASNase and the pH value played the most important role in adjusting the labeling efficiency. Reaction duration and temperature had less effect on the dye-to-protein labeling properties. The optimal condition for the labeling of cypate to L-ASNase was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/HBTU. The dynamic distribution in animal model displayed that the labeled L-ASNase firstly accumulated in liver and cleared from the enteron system. This study demonstrated that the NIR image system combined with NIR probe has the capability to trace the dynamics of protein drugs in animals for drug development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758925     DOI: 10.1007/s10895-008-0413-3

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  19 in total

1.  Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.

Authors:  J P Vieira Pinheiro; C Lanversa; G Würthwein; R Beier; J Casimiro da Palma; A von Stackelberg; J Boos
Journal:  Leuk Lymphoma       Date:  2002-10

Review 2.  Pharmacokinetic aspects of biotechnology products.

Authors:  Lisa Tang; Adam M Persky; Günther Hochhaus; Bernd Meibohm
Journal:  J Pharm Sci       Date:  2004-09       Impact factor: 3.534

Review 3.  Antibody pharmacokinetics and pharmacodynamics.

Authors:  Evelyn D Lobo; Ryan J Hansen; Joseph P Balthasar
Journal:  J Pharm Sci       Date:  2004-11       Impact factor: 3.534

Review 4.  Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins.

Authors:  Iftekhar Mahmood; Martin D Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

5.  Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.

Authors:  M Birchler; G Neri; L Tarli; C Halin; F Viti; D Neri
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

6.  Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression.

Authors:  Samuel Achilefu; Sharon Bloch; Mary A Markiewicz; Tuoxiu Zhong; Yunpeng Ye; Richard B Dorshow; Britton Chance; Kexian Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-23       Impact factor: 11.205

Review 7.  Tumor detection and visualization using cyanine fluorochrome-labeled antibodies.

Authors:  B Ballou; G W Fisher; T R Hakala; D L Farkas
Journal:  Biotechnol Prog       Date:  1997 Sep-Oct

8.  Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.

Authors:  S Folli; P Westermann; D Braichotte; A Pèlegrin; G Wagnières; H van den Bergh; J P Mach
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

9.  Time-dependent whole-body fluorescence tomography of probe bio-distributions in mice.

Authors:  Sachin Patwardhan; Sharon Bloch; Samuel Achilefu; Joseph Culver
Journal:  Opt Express       Date:  2005-04-04       Impact factor: 3.894

Review 10.  L-asparaginase: a promising chemotherapeutic agent.

Authors:  Neelam Verma; Kuldeep Kumar; Gurnoor Kaur; Sneh Anand
Journal:  Crit Rev Biotechnol       Date:  2007 Jan-Mar       Impact factor: 8.429

View more
  5 in total

Review 1.  Implicit and explicit prior information in near-infrared spectral imaging: accuracy, quantification and diagnostic value.

Authors:  Brian W Pogue; Scott C Davis; Frederic Leblond; Michael A Mastanduno; Hamid Dehghani; Keith D Paulsen
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2011-11-28       Impact factor: 4.226

2.  Binding of NIR-conPK and NIR-6T to astrocytomas and microglial cells: evidence for a protein related to TSPO.

Authors:  Michelle Sexton; Grace Woodruff; Eiron Cudaback; Faith R Kreitzer; Cong Xu; Yi Hsing Lin; Thomas Möller; Mingfeng Bai; H Charles Manning; Darryl Bornhop; Nephi Stella
Journal:  PLoS One       Date:  2009-12-18       Impact factor: 3.240

3.  Synthesis and in vivo fate of zwitterionic near-infrared fluorophores.

Authors:  Hak Soo Choi; Khaled Nasr; Sergey Alyabyev; Dina Feith; Jeong Heon Lee; Soon Hee Kim; Yoshitomo Ashitate; Hoon Hyun; Gabor Patonay; Lucjan Strekowski; Maged Henary; John V Frangioni
Journal:  Angew Chem Int Ed Engl       Date:  2011-06-07       Impact factor: 15.336

4.  Folate-polyethylene glycol conjugated near-infrared fluorescence probe with high targeting affinity and sensitivity for in vivo early tumor diagnosis.

Authors:  Fei Liu; Dawei Deng; Xinyang Chen; Zhiyu Qian; Samuel Achilefu; Yueqing Gu
Journal:  Mol Imaging Biol       Date:  2010-12       Impact factor: 3.488

5.  In vivo molecular targeting effects of anti-Sp17- ICG-Der-02 on hepatocellular carcinoma evaluated by an optical imaging system.

Authors:  Fang-qiu Li; Shi-xin Zhang; Lian-xiao An; Yue-qing Gu
Journal:  J Exp Clin Cancer Res       Date:  2011-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.